MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology...
Leading key opinion leaders to review the treatment landscape in breast and prostate cancer and the importance...
MINNEAPOLIS, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology...
- Received FDA clearance of IND for gedatolisib in combination with darolutamide - Virtual Science Day to be...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.